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ABSTRACT Na+/H+ exchanger 3 (NHE3) is the major Na+ transporter in the intestine. Serum- 
and glucocorticoid-induced kinase (SGK) 1 interacts with NHE regulatory factor 2 (NHERF2) 
and mediates activation of NHE3 by dexamethasone (Dex) in cultured epithelial cells. In this 
study, we compared short-term regulation of NHE3 by Dex in SGK1-null and NHERF2-null 
mice. In comparison to wild-type mice, loss of SGK1 or NHERF2 significantly attenuated 
regulation of NHE3 by Dex but did not completely obliterate the effect. We show that trans-
fection of SGK2 or SGK3 in PS120 cells resulted in robust activation of NHE3 by Dex. How-
ever, unlike SGK1 or SGK2, SGK3 rapidly activated NHE3 within 15 min of Dex treatment in 
both PS120 and Caco-2bbe cells. Immunofluorescence analysis showed that SGK3 colocal-
ized with NHE3 in recycling endosomes, whereas SGK1 and SGK2 were diffusely distributed. 
Mutation of Arg-90 of SGK3 disrupted the endosomal localization of SGK3 and delayed 
NHE3 activation. Activation of SGK3 and NHE3 by Dex was dependent on phosphoinositide 
3-kinase (PI3K) and phosphoinositide-dependent kinase 1 (PDK1), and Dex induced transloca-
tion of PDK1 to endosomes. Our study identifies SGK3 as a novel endosomal kinase that 
acutely regulates NHE3 in a PI3K-dependent mechanism.
INTRODUCTION
Glucocorticoids (GCs) are widely used to treat inflammatory bowel 
disease (Campieri et al., 1997). In addition to antiinflammatory ef-
fects, GCs show a direct effect on NaCl and water absorption in the 
intestine by targeting Na+/H+ exchanger 3 (NHE3; Charney et al., 
1975), which is the major Na+ transporter located at the brush bor-
der membrane of the intestinal epithelium (He and Yun, 2010). Early 
studies showed that GCs stimulate NHE3 primarily through a ge-
nomic effect that increases NHE3 transcripts (Yun et al., 1993). More 
recently, GCs were implicated in nongenomic regulation of NHE3, 
with GCs stimulating NHE3 activity without changing NHE3 expres-
sion levels, and serum- and glucocorticoid-induced kinase (SGK) 1 
was subsequently shown to mediate nongenomic regulation of 
NHE3 by GCs (Baum et al., 1994; Yun et al., 2002a; Wang et al., 
2005, 2007).
SGK1 was initially identified by a differential screen of a rat mam-
mary tumor cell line in search of GC-inducible genes (Webster et al., 
1993), and a subsequent protein sequence homology search identi-
fied two additional SGK isoforms, SGK2 and SGK3 (also known as 
cytokine-independent survival kinase; Kobayashi et al., 1999). A 
body of evidence shows that SGKs share similar functions in regula-
tion of a broad range of ion transporters and channels, including 
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de la Rosa et al., 1999; Naray-Fejes-Toth et al., 1999; Debonneville 
et al., 2001; Friedrich et al., 2003; Helms et al., 2003), K+ channels 
(Gamper et al., 2002; Yun et al., 2002b; Embark et al., 2003), amino 
acid transporter (Bohmer et al., 2010), and Na+, K+-ATPase (Henke 
et al., 2002). However, it is noteworthy that these SGK isoforms dif-
fer in some aspects of their functions: SGK1 and SGK3, but not 
SGK2, stimulate the calcium channel TRPV5 (Embark et al., 2004); 
SGK3, but not SGK1, mediates activation of glutamate receptor 1 
and human ether-a-go-go channel (Maier et al., 2006). SGK1 stimu-
lates GluR6 (Strutz-Seebohm et al., 2005b), whereas SGK3 stimu-
lates GluR1 (Strutz-Seebohm et al., 2005a). Furthermore, the pheno-
types of mice deficient in SGK1 or SGK3 are distinct, clearly 
demonstrating nonredundant functions of the SGK proteins (Wulff 
et al., 2002; McCormick et al., 2004).
At the protein level, SGKs have 50% homology in their car-
boxyl-termini and only 15% homology in their NH2-termini 
(Kobayashi et al., 1999). In comparison to SGK1, SGK2 contains a 
relatively short NH2-terminus, whereas SGK3 has a longer NH2-
terminus comprising a phox homology (PX) domain. The PX do-
main was originally found as a conserved domain in the p40phox 
and p47phox subunits of NADPH-oxidase complex (Ponting, 1996). 
The PX domain binds phosphoinositide, and it is present in many 
proteins involved in intracellular trafficking, such as sorting nexins 
(Worby and Dixon, 2002). In the case of SGK3, studies have shown 
that the PX domain is essential for targeting SGK3 to endosomes 
(Jun et al., 2001; Virbasius et al., 2001; Tessier and Woodgett, 
2006), and this PX-dependent endosomal targeting results in dis-
tinct subcellular localization of SGK3 relative to SGK1 and SGK2. 
Interestingly, NHE3 resides in the endosomal compartment, which 
constitutes a major part of NHE3 regulation (Biemesderfer et al., 
1997; D’Souza et al., 1998; Kurashima et al., 1998), raising the pos-
sibility that SGK3 colocalizes with NHE3 in the same endosomal 
compartments.
In cultured epithelial cells, we have shown previously that SGK1 
acutely regulates NHE3 activity, and this regulation requires the 
presence of NHE regulatory protein 2 (NHERF2), which tethers 
NHE3 and SGK1 to facilitate phosphorylation of NHE3 by SGK1 
(Yun et al., 2002a; Wang et al., 2005, 2007). The importance of SGK1 
in regulation of NHE3 is supported by the report that dexametha-
sone (Dex)-induced activation of NHE3 is significantly compromised 
in SGK1-null intestine (Grahammer et al., 2006). However, animals 
were treated for 4 d with Dex in the former study, and whether short-
term regulation of NHE3 is also perturbed has not been determined. 
In the current study, we investigated the effects of short-term Dex 
treatment on NHE3 activity in SGK1-null and NHERF2-null intestine. 
Additionally, we show that SGK3 colocalized with NHE3 in recycling 
endosomes acutely stimulates NHE3, providing a new insight into 
the role of SGK3 and acute regulation of NHE3.
RESULTS
SGK1 and NHERF2 play important roles in Dex-mediated 
stimulation of NHE3 in ileum
It was shown previously that treatment of SGK1-null mice with Dex 
for 96 h resulted in an ∼40% increase in NHE3 activity compared with 
∼110% in wild-type (WT) mice (Grahammer et al., 2006). For the cur-
rent study, we mated Sgk1flox/flox mice with Villin-Cre mice to generate 
Sgk1flox/flox;Villin-Cre mice, in which the Villin promoter directs the de-
letion of Sgk1 gene in the epithelial cells in the intestine (Pinto et al., 
1999). The expression of SGK1 was examined by reverse transcrip-
tion PCR (RT-PCR) and Western blotting to confirm the absence of 
SGK1 in the intestinal epithelial cells of Sgk1flox/flox;Villin-Cre mice 
(Supplementary Figure S1, A and B).
Because our initial proposal for the role of SGK1 in NHE3 regula-
tion pertains to short-term rather than chronic regulation (Grahammer 
et al., 2006), we investigated the effects of Dex treatment for 4 h as a 
short-term treatment and 24 h as a long-term treatment. The basal 
rate of Na+-dependent pH change by NHE3 measured in the pres-
ence of NHE1 and NHE2 inhibitor Hoe-694 in isolated villi of 
Sgk1flox/flox and Sgk1flox/flox;Villin-Cre mice was not changed by the loss 
of SGK1 (Figure 1). Dex treatment of Sgk1flox/flox mice for 4 and 24 h 
increased NHE3 activity in the ileum by ∼120% (Figure 1, A and B). In 
contrast, the loss of SGK1 in Sgk1flox/flox;Villin-Cre mice markedly de-
creased the effect of Dex resulting in only ∼25–30% increase in NHE3 
activity (Figure 1, C and D). These findings reveal that SGK1 plays a 
significant role in, but is not obligatory for, Dex-mediated stimulation 
of NHE3. To ensure that the remaining increase in Na+-dependent pH 
change in Sgk1flox/flox;Villin-Cre ileal epithelial cells is due to NHE3 
activity, Na+-dependent pH recovery was measured in the presence 
of the NHE3 inhibitor S-3226. Our results showed that the Hoe-694-
insensitive Na+/H+ exchange activity was ablated by S-3226 (Supple-
mentary Figure S2, A and B), confirming its NHE3 origin.
We have shown previously that NHERF2 is necessary for SGK1-
dependent regulation of NHE3 (Yun et al., 2002a). To determine the 
role of NHERF2 in vivo, we examined the effects of Dex treatment for 
4 and 24 h in isolated villi of Nherf2−/− mice. Immunoblotting con-
firmed that NHERF2 is absent in the mucosa of Nherf2−/− mice intes-
tine, and that the expression level of SGK1 is not changed in Nherf2−/− 
mice (Supplementary Figure S1B). As for Sgk1flox/flox;Villin-Cre villi, 
the loss of NHERF2 resulted in ∼30% and ∼45% increases at 4 and 24 
h, respectively, compared with ∼120% in WT villi (Figure 1, E and F). 
These studies show that SGK1 and NHERF2 are needed for the acti-
vation of NHE3 activity by Dex at 4 and 24 h, which is consistent with 
previous studies using cultured cells. However, the residual activation 
of NHE3 in the absence of SGK1 or NHERF2 suggests that additional 
means for NHE3 activation must be present (Yun et al., 2002a). One 
potential mechanism involves increased NHE3 expression, but our 
earlier study showed that NHE3 protein abundance does not change 
at 4 h (Wang et al., 2007), requiring an alternative explanation.
Differential regulation of NHE3 by SGK1, SGK2, and SGK3
Because other SGK isoforms, SGK2 and SGK3, can mediate similar 
effects, we sought to determine whether SGK2 or SGK3 regulates 
NHE3 activity in response to Dex treatment. The presence of SGK2 
and SGK3 in small intestine was confirmed by RT-PCR. The expres-
sion levels of SGK2 and SGK3 mRNA in intestinal epithelial cells 
were not changed by the loss of SGK1 in Sgk1flox/flox;Villin-Cre mice 
(Supplementary Figure S1A). PS120 cells stably expressing rabbit 
NHE3 with a vesicular stomatitis virus glycoprotein (VSVG) epitope 
fused at the carboxyl-terminus, PS120/NHE3V, were transfected 
with hemagglutinin (HA)-SGK1, -SGK2, or -SGK3, and the resulting 
cells were treated with 1 μM Dex (Figure 2A). Overexpression of 
SGK1 did not mediate an apparent activation of NHE3 by Dex, as 
PS120 cells lacked NHERF2 expression (Figure 2B), which is required 
for SGK1-mediated NHE3 regulation (Yun et al., 2002a). In contrast, 
both SGK2 and SGK3 showed significant increases in NHE3 activity 
at both 4 and 24 h of Dex treatment (Figure 2, C and D), suggesting 
that the remaining NHE3 activation in Sgk1flox/flox;Villin-Cre mice 
might have been due to the activities of SGK2 and SGK3. Surpris-
ingly, Dex treatment showed a marked increase in NHE3 activity in 
PS120/NHE3V/HA-SGK3 cells at 15 min (Figure 2D), but not in cells 
expressing SGK1 or SGK2. To our knowledge, this is the first obser-
vation of such a rapid effect by Dex on NHE3. However, we did not 
observe any effect at 5 min, and we considered 15 min as the earli-
est time needed for Dex to regulate NHE3.
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Intriguingly, NHE3 activity was signifi-
cantly increased (∼25%) in Sgk1flox/flox mice 
(Figure 3A), validating the acute regulation 
of NHE3 by Dex. Moreover, Dex stimulated 
NHE3 activity in both Sgk1flox/flox;Villin-Cre 
and Nherf2−/− villi to the same extent as 
WT villi (Figure 3, A and B), further demon-
strating that Dex-induced acute (15 min) 
stimulation of NHE3 in the intestine is inde-
pendent of SGK1 and NHERF2. We con-
firmed that the acute pH recovery was due 
to NHE3 by using S-3226 (Supplementary 
Figure S2C).
Differential regulation of SGK1, SGK2, 
and SGK3 kinase activity by Dex
Despite the similarity in SGK isoforms, 
SGK1 is the only isoform for which expres-
sion is regulated by GCs. However, there is 
the possibility that Dex treatment regulates 
the kinase activity without a change in the 
expression level. Therefore we examined 
whether the kinase activity of these SGKs is 
regulated by Dex. We again used PS120/
NHE3V cells expressing HA-SGK1, HA-
SGK2 or HA-SGK3 to determine the effect 
of Dex on SGK kinase activity. These cells 
have an advantage in that the expression 
of SGKs is under the control of cytomega-
lovirus (CMV) promoter and is not altered 
by Dex. Cells were treated with Dex for 
0–24 h, and HA-SGKs were immunopre-
cipitated with anti-HA antibodies. The 
amounts of SGKs were normalized by West-
ern immunoblot analysis of an aliquot of 
immunoprecipitated proteins to ensure that 
the identical amount of SGK protein was 
used in the kinase assay. We determined 
SGK kinase activity by two approaches: by 
using [γ-32P]ATP and by a nonradioisotope 
time-resolved fluorescence–fluorescence 
resonance energy transfer (TR-FRET) 
method. Figure 4 shows that the kinase ac-
tivities of SGK1, SGK2, and SGK3 were 
similarly increased at 4 and 24 h of Dex 
treatment. However, unlike that of SGK1 or 
SGK2 (Figure 4, A and B), SGK3 activity was 
markedly increased at 15 min (Figure 4C). 
The nonradioactive TR-FRET assay yielded 
similar results (Supplementary Figure S3). 
Although the extent of increases was 
smaller in the TR-FRET assay, it is important 
to note that the results were qualitatively 
identical to [γ-32P]-labeling of Crosstide. We 
therefore used the TR-FRET method to de-
termine kinase activity in the subsequent 
experiments.
SGK2 and SGK3 mediate exocytotic trafficking 
and phosphorylation of NHE3
We showed previously that SGK1 stimulates NHE3 activity by in-
creasing NHE3 expression at the cell surface (Wang et al., 2005). To 
In light of our unexpected findings, we examined whether Dex 
acutely regulates NHE3 in vivo. Because 15-min treatment of ani-
mals in vivo is not feasible, isolated villi were treated with 1 μM Dex 
ex vivo for 15 min prior to measurement of NHE3 activity. 
FIGURE 1: SGK1 and NHERF2 play important roles in Dex-induced activation of NHE3 in 
mouse ileum. Mice were injected intraperitoneally with Dex at 2 mg/kg body weight. After 4 
or 24 h, villi were isolated from the ileum and NHE3 activity was measured in the presence of 
50 μM Hoe-694 (NHE1 and NHE2 inhibitor). Increased rates of pH recovery following 4 or 24 h 
of Dex treatment were observed. (A) Representative traces of Na+-dependent pH recovery in 
Sgk1flox/flox mice are shown. (B) NHE3 activities in Sgk1flox/flox villi are presented as the rate of 
Na+-dependent pH change by determining ΔpHi/Δtime at pHi 6.5 using typical traces shown in 
(A). NHE3 activities are shown as mean ± SE. (C) Representative traces of Na+-dependent pH 
recovery in the ileal villi prepared from Sgk1flox/flox;Villin-Cre mice are shown. (D) NHE3 activities 
in Sgk1flox/flox;Villin-Cre villi are presented as the rate of Na+-dependent pH change at pHi 6.5. 
Stimulation of NHE3-dependent pH recovery is significantly attenuated in Sgk1flox/flox;Villin-Cre 
mice compared with Sgk1flox/flox mice. NHE3 activities at pHi 6.5 are shown in (E) WT and (F) 
Nherf2−/− mice. For all experiments, n = 3–4 mice and 6–8 villi per mouse were used. *, p < 0.01 
and **, p < 0.05, compared with the untreated control.
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15 min was observed (Figure 5A). In con-
trast, the presence of SGK3 resulted in a sig-
nificant increase in surface NHE3 at both 15 
min and 4 h of Dex treatment (Figure 5A).
We have previously shown that SGK1-
mediated activation of NHE3 is dependent 
on phosphorylation of NHE3 at S663 
(Wang et al., 2005). Because SGK2 and 
SGK3 recognize the same phosphorylation 
motif (Kobayashi et al., 1999), we sought to 
determine the importance of S663 in NHE3 
regulation by SGK2 or SGK3. PS120/opos-
sum NHE3 (OKNHE3) and PS120/OKNHE3-
S663A (OKNHE3 with a mutation of serine 
663 to alanine) cells transfected with HA-
SGK2 or HA-SGK3 were treated with Dex. 
Dex treatment for 4 h stimulated the activity 
of NHE3 as we have shown earlier, but the 
mutation of S663A ablated the effect 
(Figure 5B). For SGK3, we treated the cells 
for 15 min, but as for SGK2, NHE3-S663A 
did not respond to Dex treatment (Figure 5C). 
Although direct phosphorylation of NHE3 
by SGK2 or SGK3 was not shown here, the 
results demonstrate that the presence of 
S663 is required for NHE3 regulation by 
SGK2 and SGK3.
SGK3 and NHE3 colocalize in recycling 
endosomes
We then asked whether the distinct response 
of NHE3 to SGK3 could be related to their 
spatial localizations. Immunofluorescence 
analysis of PS120/NHE3V cells (Figure 6A, 
top and middle) showed that both SGK1 
(green) and SGK2 (green) were diffusely expressed throughout the 
cells. SGK1 and SGK2 partially colocalized with NHE3 (red) based on 
the overlap of fluorescence labels but did not show any distinct 
compartmentalization with NHE3. In contrast, SGK3 labeling showed 
localization in endosome-like compartments 
(Figure 6A, bottom) and, importantly, SGK3 
(green) colocalized with NHE3 (red) in these 
vesicles. The endosomal location of SGK3 
was confirmed by costaining with Rab5 
(Figure 6B, bottom, red), an early endosome 
marker In contrast, neither SGK1 nor SGK2 
colocalized with Rab5 in early endosomes 
(Figure 6B, top and middle). Furthermore, 
we examined whether the SGKs are ex-
pressed in recycling endosomes. PS120/
NHE3V cells were transfected with green 
fluorescent protein (GFP)-Rab11 (a marker 
for recycling endosome) together with FLAG-
tagged SGK1, SGK2, or SGK3. Figure 6C 
shows that SGK1 and SGK2 (red) were not 
found in recycling endosomes where Rab11 
(green) is expressed. In contrast, SGK3 (red) 
and NHE3 (blue) colocalized with Rab11 
(green) in recycling endosomes (Figure 6D).
We next examined whether the endo-
somal localization of SGK3 is important for 
acute NHE3 regulation. It was shown that 
determine whether SGK2 and SGK3 similarly increase NHE3 
expression in the plasma membrane, we performed a surface bioti-
nylation assay. Surface NHE3 abundance was significantly increased 
at 4 h of Dex treatment in SGK2-expressing cells, but no change at 
FIGURE 2: SGK3 rapidly activates NHE3 in response to Dex. (A) PS120/NHE3V cells were stably 
transfected with HA-SGK1, HA-SGK2, and HA-SGK3, and the expression levels of SGKs were 
determined by immunoblotting using an anti-HA antibody. Western blot of β-actin was used as 
loading control. PS120/NHE3V cells expressing (B) HA-SGK1, (C) HA-SGK2, or (D) HA-SGK3 
were treated with 1 μM Dex for t = 0, 15 min, 4 h, or 24 h, followed by determination of NHE3 
activity. The rates of pH recovery at pHi 6.7 are shown. n = 8. *, p < 0.01 compared with the 
untreated control.
FIGURE 3: Dex acutely activates NHE3 in mouse intestine lacking SGK1 or NHERF2. (A) Villi 
were isolated from the Sgk1flox/flox and Sgk1flox/flox;Villin-Cre ilea and were treated ex vivo with 
1 μM Dex or carrier for 15 min prior to measurement of NHE3 activity in the presence of 
Hoe-694. The rates of pH recovery at pHi 6.6 are shown. (B) The rates of pH recovery at pHi 6.6 
in WT and Nherf2−/− ilea treated with Dex for 15 min are shown. For all experiments, n = 3 mice 
and six villi per mouse were used. *, p < 0.01 and **, p < 0.05, compared with the control.
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cence staining confirmed that the R90A mutation perturbed the cel-
lular location of SGK3 and, unlike WT SGK3, the SGK3-R90A mutant 
diffusely expressed throughout the cytoplasm, which appears simi-
lar to the expression patterns of SGK1 and SGK2; consequently, 
SGK3-R90A did not colocalize with NHE3 (Figure 7B). Intriguingly, 
the effect of the R90A mutation on endo-
somal localization of SGK3 was also ex-
tended to regulation of its activity in re-
sponse to Dex. The kinase activity of 
SGK3-R90A was elevated at 4 and 24 h, but 
not at 15 min, of Dex treatment (Figure 7C), 
suggesting that the acute regulation of 
SGK3 by Dex is related to the endosomal 
localization of SGK3. Moreover, SGK3-R90A 
failed to activate NHE3 activity at 15 min, 
but its effect was delayed until 4 h of Dex 
treatment (Figure 7D). These findings indi-
cate that endosomal localization enables 
SGK3 to acutely regulate NHE3.
SGK3-mediated activation of NHE3 is 
dependent on GR, phosphoinositide 
3-kinase, and phosphoinositide-
dependent kinase 1
Recent evidence has emphasized the short-
term effects of GCs, but the mechanism of 
how GCs exert acute effects is incompletely 
understood. The presence of a G protein–
coupled GC receptor (GR) that is insensitive 
to the GR antagonist, RU486 (RU), has been 
proposed (Maier et al., 2005). Hence we 
first examined whether RU-insensitive GR is 
involved in the acute regulation of SGK3 by 
Dex. The preincubation of PS120/NHE3V/
HA-SGK3 cells with RU (1 μM) did not affect 
the basal SGK3 activity but completely ab-
rogated the Dex-induced rapid effect on 
SGK3 activity, suggesting the conventional 
GR and not the membrane-bound GR regu-
lates SGK3 (Figure 8A). SGKs are related to 
Akt and are regulated by phosphoinositide 
3-kinase (PI3K) and phosphoinositide- 
dependent kinase 1 (PDK1; Kobayashi et al., 
the PX domain of SGK3 is critical for its endosomal localization, and 
mutation of R90 located in the PX domain disrupts the endosomal 
localization of SGK3 (Tessier and Woodgett, 2006). Therefore we 
expressed SGK3 or SGK3-R90A (SGK3 containing a mutation of 
Arg90 to Ala) in PS120/NHE3V cells (Figure 7A). Immunofluores-
FIGURE 4: SGK3 kinase activity is acutely stimulated by Dex. PS120/NHE3V cells expressing HA-SGK1, HA-SGK2, or 
HA-SGK3 were treated with 1 μM Dex for t = 0, 15 min, 4 h, or 24 h. SGK proteins were purified by immunoprecipitation 
with an anti-HA antibody. To ensure the equal loading of immunoprecipitated SGKs, an aliquot of eluted protein was 
subjected to Western blotting using anti-HA antibody. Equal amounts of each SGK protein were used for in vitro kinase 
assay by using [γ-32P]ATP, as detailed in Materials and Methods. The activities of (A) SGK1, (B) SGK2, and (C) SGK3 are 
shown relative to the basal SGK activity. n = 3. *, p < 0.01 compared with the untreated control.
FIGURE 5: SGK2 and SGK3 increase NHE3 surface expression and the S663A mutation blocks 
the activation. (A) PS120/NHE3V/pcDNA, PS120/NHE3V/HA-SGK2, and PS120/NHE3V/
HA-SGK3 cells were treated with 1 μM Dex for t = 0, 15 min, or 4 h, and the amount of NHE3 
protein on the plasma membrane was determined by surface biotinylation, as detailed in 
Materials and Methods. The amount of surface (S) NHE3 was normalized to total (T) NHE3, and 
relative changes (%) are shown below the Western blots. n ≥ 3. (B) PS120/OKNHE3/HA-SGK2 
and PS120/OKNHE3-S663A/HA-SGK2 cells were treated with 1 μM Dex for 4 h and NHE3 
activity was measured. The rates of pH recovery at pHi 6.8 are shown. n = 6. (C) PS120/
OKNHE3/HA-SGK3 and PS120/OKNHE3-S663A/HA-SGK3 cells were treated with 1 μM Dex 
for 15 min, and NHE3 activity was determined. The rates of pH recovery at pHi 6.8 are shown. 
n = 6. n.s., not significant. *, p < 0.01, compared with the untreated control.
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induced PI3K-PDK1 pathway is not specific for acute (15 min) 
NHE3 activation by SGK3. We did not examine the role of PDK1 
for SGK1 in PS120 cells, since SGK1 showed no effect on NHE3 
(Figure 2B) unless NHERF2 was coexpressed, but we showed previ-
ously that regulation of NHE3 by SGK1 is PI3K-dependent (Yun et al., 
2002a).
If PDK1 is important for both SGK2- and SGK3-dependent reg-
ulation of NHE3, what allows the acute regulation of SGK3? To 
delineate the role of PDK1 in the rapid activation of SGK3 and 
NHE3, we examined the temporospatial location of phosphoryla-
tion of PDK1 (p-PDK1: an active form of PDK1 kinase) at Ser241 
relative to SGK3 in response to Dex treatment. Fluorescence label-
ing of SGK3 (Figure 8F, green) partially colocalized with p-PDK1 
(Figure 8F, red) under basal conditions, whereas treatment with 
Dex for 15 min resulted in increased overlap of their fluorescence 
labels (Figure 8F). A quantitative determination of colocalization of 
SGK1 and p-PDK1 showed a significant increase in colocalization 
coefficient induced by Dex treatment (Figure 8G). An x,z scan 
shows that Dex also increased colocalization of p-PDK1 and SGK3 
1999; Park et al., 1999). In addition, it was shown that Dex stimulates 
PI3K activity by potentiating binding of GR to the p85 subunit of 
PI3K (Hafezi-Moghadam et al., 2002). Hence we tested the involve-
ment of PI3K by using the PI3K inhibitor, LY294002 (LY). Pretreatment 
with LY (20 μM) completely blocked the activation of SGK3 activity by 
15 min of Dex treatment (Figure 8A). Similarly, RNA interference of 
PDK1 by short-hairpin RNA (shRNA), which reduced the PDK1 ex-
pression by ∼70% (Figure 8B), ablated the stimulatory effect of Dex 
on SGK3 activity (Figure 8C). Consistent with the inhibition of SGK3 
kinase activity, the acute regulation of NHE3 transport activity by Dex 
in SGK3-expressing cells was completely blocked when cells were 
pretreated with RU or LY (Figure 8D), or with knockdown of PDK1 
(Figure 8E). Taken together, these data show that acute activation of 
SGK3 and NHE3 by Dex is through the GR-PI3K-PDK1 pathway. Be-
cause the effects of SGK2 and SGK3 on NHE3 at a later time point 
(4 h) are similar, we determined whether the delayed regulation of 
NHE3 by SGK2 and SGK3 is also dependent on PDK1. Knockdown 
of PDK1 ablated activation of NHE3 activity in cells expressing SGK2 
or SGK3 (Supplementary Figure S4), suggesting that the Dex-
FIGURE 6: SGK3 colocalizes with NHE3 in recycling endosomes. (A) Cellular distribution of HA-tagged SGK1-3 (green) 
and NHE3V (red) in PS120 cells was determined by indirect immunofluorescence with anti-HA and anti-VSVG antibodies, 
respectively. The inset shows a magnified image of the boxed area. (B) Cellular localization of HA-tagged SGK1-3 
(green) and Rab5 (red) in PS120 cells was determined with anti-HA and anti-Rab5 antibodies, respectively. (C) PS120/
NHE3V cells were transfected with FLAG-tagged SGK1 or SGK2 and GFP-Rab11. The colocalization of SGK1 or SGK2 
with Rab11 was determined with anti-FLAG antibody. (D) PS120/NHE3V cells were transfected with FLAG-SGK3 and 
GFP-Rab11. The colocalization of SGK3 (red) and NHE3V (blue) with GFP-Rab11 (green) was determined with anti-FLAG 
and anti-VSVG antibodies, respectively. Scale bar: 10 μm.
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by mobilizing PDK1 to endosomal compartments in the cytoplasm 
and on the membrane, where it activates SGK3 that in turn phos-
phorylates NHE3.
SGK3 mediates acute activation of NHE3 in Caco-2bbe 
epithelial cells
To reproduce the regulation of NHE3 via SGK3 in intestinal epithelial 
cells, we expressed HA-SGK3 in Caco-2bbe cells stably expressing 
human NHE3V, Caco-2bbe/hNHE3V (Lin et al., 2010). Dex treatment 
for 15 min stimulated NHE3 activity in HA-SGK3–expressing cells 
but not in pcDNA-transfected control cells (Figure 9A). Confocal 
in the perimembrane areas (Supplementary Figure S5). To deter-
mine whether Dex mobilizes p-PDK1 to endosomal compartments, 
we determined the expression patterns of p-PDK1(red) in GFP-
Rab11 (green) upon 15 min of Dex treatment (Figure 8, H and I). 
The results show that the expression of p-PDK1 in recycling endo-
somes increased following Dex treatment. We also examined 
whether Dex-induced mobilization of p-PDK1 occurs in intestinal 
epithelial cells. Consistent with the findings in PS120 cells, Dex 
increased p-PDK1 expression in recycling endosomes in the hu-
man intestinal epithelial Caco-2bbe cells (Supplementary Figure 
S6). These findings demonstrate that Dex acutely activates NHE3 
FIGURE 7: Acute regulation of NHE3 by SGK3 is dependent on the endosomal localization of SGK3. (A) PS120/NHE3V 
cells were expressed with HA-SGK3 or HA-SGK3-R90A, and the expression levels of SGK3 and SGK3-R90A in PS120/
NHE3V cells were examined with anti-HA antibody. (B) Cellular distribution of SGK3 (green) or SGK3-R90A (green) with 
NHE3 (red) in PS120 cells was examined with anti-HA and anti-VSVG antibodies, respectively. Scale bar: 10 μm. 
(C) PS120/NHE3V/HA-SGK3-R90A cells were treated with Dex for t = 0, 15 min, 4 h, or 24 h, and SGK3-R90A protein 
was purified by immunoprecipitation for kinase assay. The kinase activities of SGK3-R90A are shown relative to the basal 
activity. n = 3. (D) PS120/NHE3V/HA-SGK3-R90A cells were treated with 1 μM Dex for t = 0, 15 min, or 4 h, followed by 
measurement of NHE3 activity. The rates of pH recovery at pHi 6.7 are shown. n = 6. *, p < 0.01 and **, p < 0.05, 
compared with the untreated control.
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of GCs (Losel and Wehling, 2003), although the underlying mecha-
nisms remain unclear. It was shown that Dex stimulates PI3K activity 
by potentiating binding of GR to the p85 subunit of PI3K (Hafezi-
Moghadam et al., 2002; Hu et al., 2009). Unlike the classical activa-
tion of PI3K by insulin/IGF-1 receptors or tyrosine kinase receptors 
that occurs as a membrane-based event, GR-dependent activation 
of PI3K happens most likely in the cytoplasm with PI3K being se-
questered away from the membrane (Hu et al., 2009), which in turn 
activates PDK1. A previous study showed that all SGKs are phos-
phorylated by PDK1 (Kobayashi et al., 1999), and knockdown of 
PDK1 abolished Dex-induced regulation of SGK2, SGK3, and NHE3 
(Figures 8 and S4). We did not determine whether PDK1 directly 
regulates SGK1, but it was shown that PDK1 is required for PI3K-
mediated activation of SGK1 and that SGK1-dependent activation 
of NHE3 involves PI3K (Park et al., 1999; Yun et al., 2002a). Hence 
it is highly likely that PDK1 links PI3K to SGK1.
So, what makes SGK3 different from other SGKs? We showed 
that SGK1 and SGK2 are diffusely distributed throughout the cyto-
plasm, with some in nuclei, but none on endosomes (Figure 6). On 
the other hand, SGK3 is distinctly localized to recycling and early 
endosomes, which is consistent with previous reports using HEK293 
and COS cells (Jun et al., 2001; Virbasius et al., 2001; Tessier and 
Woodgett, 2006). On activation with Dex, p-PDK1 is recruited to 
endosomes, where it activates SGK3, as demonstrated by increased 
colocalization of p-PDK1 with SGK3 and Rab11 (Figures 8 and S6). 
In agreement with our findings, a recent study demonstrated that 
SGK3 facilitates the recruitment of p-PDK1 to endosomes when 
SGK3 is preactivated at S486 through PI3K signaling (Slagsvold 
et al., 2006). Hence our current study demonstrates that the core of 
the acute regulation of SGK3 is its endosomal localization. The im-
portance of endosomal residence of SGK3 for its regulation of NHE3 
was further demonstrated by the finding that the R90A mutation in 
SGK3, which perturbed the endosomal localization of SGK3, lost its 
acute effect on NHE3 regulation, although delayed activation of 
NHE3 was not affected. How Dex induces delayed effects on NHE3 
is not clear. We propose that SGK1 and SGK2, as well as the SGK3-
R90A mutant deficient in the endosome-targeting PX domain, lack 
the spatial arrangement for a rapid access by PDK1 in response to 
Dex. Instead, much longer time is required for PDK1 and these 
SGKs to come in contact for activation of SGKs. In addition, cytoso-
lic SGK1 and SGK2 may need to move through the cytoplasmic 
matrix to interact with and phosphorylate NHE3 (Figure 10).
Since the seminal studies by Grinstein and his colleagues in the 
late 1990s that showed NHE3 in recycling endosomes (D’Souza 
et al., 1998; Kurashima et al., 1998), the trafficking of NHE3 protein 
from recycling endosomes has been recognized as the pivotal step 
in NHE3 regulation. The former studies showed that inhibition of 
PI3K results in a pronounced loss of NHE3 from the cell surface and 
its accumulation in an intracellular endosomal compartment. More-
over, PI3K regulates NHE3 by several hormones and growth factors, 
including insulin, lysophosphatidic acid, and basic fibroblast growth 
factor (Janecki et al., 2000; Lee-Kwon et al., 2003; Fuster et al., 
2007). However, the identity of the effector(s) of PI3K signaling tar-
geting NHE3 in recycling endosomes has remained undefined. Our 
present study is the first to identify SGK3 as a PI3K-signaling effector 
in recycling endosomes that activates NHE3. We therefore specu-
late that the endosomal localization of SGK3 has a broader implica-
tion on NHE3 regulation. In addition, the localization of SGK3 in 
recycling endosomes and the broad tissue expression of SGK3 sug-
gest that SGK3, under basal or induced conditions, might be in-
volved in regulating other proteins that traffic between intracellular 
pools and the plasma membrane.
immunofluorescence analysis showed that SGK3 (green) colocalized 
with NHE3 (red) in the subapical compartments (Figure 9B). A cross-
sectional view of the cells near the top surface and a stacked view 
show the apical expression of NHE3, which overlaps with fluores-
cent wheat germ agglutinin (WGA) that labels glycoprotein at the 
plasma membrane (Figure 9C, Cont). Treatment of the cells with 
Dex for 15 min enhanced the overlap of fluorescence labels of 
NHE3 and WGA, indicating increased surface NHE3 abundance in 
response to Dex (Figure 9C, Dex). The results from immunofluores-
cence analysis were confirmed by a surface biotinylation assay, 
which showed increased NHE3 protein abundance at the apical 
membrane (Figure 9D).
DISCUSSION
We have previously shown that SGK1 plays a critical role in Dex-in-
duced activation of NHE3 in cultured fibroblast and epithelial cells 
(Yun et al., 2002a; Wang et al., 2005). However, the critical impor-
tance of SGK1 for NHE3 regulation in vivo has remained elusive 
until the recent report by Grahammer et al. (2006). In that study, the 
effects of Dex on intestinal NHE3 regulation were compared be-
tween WT and SGK1-null mice following a 4-d Dex treatment. 
Therefore we revisited Dex-induced regulation of NHE3 in the 
SGK1-null intestine to determine the effects at earlier time points at 
which NHE3 activity is increased but NHE3 abundance is not 
changed by Dex treatment. Moreover, we used mice with intestinal 
epithelia–specific deletion of SGK1. Our data showed that SGK1 
plays a major role in short-term (4 h) regulation of NHE3 by Dex, and 
also confirmed the earlier report by Grahammer and coworkers. In 
addition, in agreement with our previous in vitro study that NHERF2 
is required for SGK1-dependent regulation of NHE3, the NHERF2-
null intestine showed decreased responses to Dex. However, the 
loss of neither SGK1 nor NHERF2 completely ablated the stimula-
tory effect of Dex. Our previous study showed that NHE3 abun-
dance is not changed until much later than 4 h of Dex treatment 
and hence it is unlikely that the residual effect on NHE3 is simply 
due to changes in NHE3 abundance. Because SGKs share similar 
functions in regulation of various ion channels and transporters 
(Lang et al., 2003, 2006), we determined whether SGK2 or SGK3 is 
involved in NHE3 regulation. Our current study using PS120 cells 
showed that both SGK2 and SGK3 activate NHE3. Our previous 
study has shown that SGK1, but not SGK2 and SGK3, interacts with 
NHERF2 (Yun et al., 2002a). Consistently, stimulation of NHE3 activ-
ity by SGK2 and SGK3 was independent of NHERF2, occurring in 
PS120 cells that lack endogenous NHERF2, whereas SGK1 failed to 
regulate NHE3. A recent study showed that constitutively active 
SGK2, but not SGK1, stimulates NHE3 activity in OK cells (Pao et al., 
2010). This finding is consistent with previous studies that OK cells 
express NHERF2 at low levels (Yun et al., 2002a). Apart from not 
needing NHERF2, all SGKs share common mechanisms that involve 
increased NHE3 abundance at 4 and 24 h of Dex treatment and the 
inability to regulate NHE3-S663A. In light of the high similarity of 
the kinase domains of SGK1–3, it is not surprising that they mediate 
Dex-induced activation of NHE3 via similar mechanisms. However, 
accumulating evidence shows that SGK3 plays distinct roles from 
SGK1. SGK3 is important for postnatal hair follicle growth (McCor-
mick et al., 2004), and a recent study showed that expression of 
SGK3 is estrogen-inducible in breast cancer cells (Wang et al., 2011). 
In the current study, we showed for the first time that SGK3, but not 
SGK1 or SGK2, mediates an acute activation of NHE3 at as early as 
15 min in response to Dex.
GC-mediated effects generally involve GR-dependent gene reg-
ulation. However, recent studies have highlighted short-term effects 
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In summary, our study showed that SGK1 plays a major role in 
Dex-mediated activation of NHE3 in vivo in the intestine, but some 
NHE3 activity regulation is independent of SGK1 and NHERF2. We 
showed that both SGK2 and SGK3 contribute to NHE3 activation, 
but SGK3 uniquely colocalizes with NHE3 to recycling endosomes, 
enabling acute regulation of NHE3 via the PI3K-PDK1 pathway.
MATERIALS AND METHODS
Animals
Generation of mice with the sgk1 gene flanked by loxP (Sgk1flox/flox) 
in C57BL/6 background was reported previously (Fejes-Toth et al., 
2008). Intestinal epithelia-specific deletion of SGK1 was achieved by 
mating Sgk1flox/flox mice with Villin-Cre transgenic mice. Nherf2-null 
(Nherf2−/−) mice in C57BL/6 background have been previously de-
scribed (Lin et al., 2009). Genotypes were determined by PCR on tail 
DNA. In all experiments, age- and sex-matched littermates of Sgk-
1flox/flox and Sgk1flox/flox;Villin-Cre or WT and Nherf2−/− mice were 
studied. Animals were maintained and experiments were performed 
under the institutional guidelines of Emory University.
Antibodies and plasmid constructs
Anti-HA, anti-PDK1, and anti–p-PDK1(Ser241) antibodies were pur-
chased from Cell Signaling Technology (Danvers, MA). Anti-HA an-
tibody was obtained from Covance (Denver, PA). Rabbit and mouse 
anti-FLAG antibodies were purchased from Sigma (St. Louis, MO) 
and anti-Rab5 antibody from Santa Cruz Biotechnology (Santa Cruz, 
CA). The pBK plasmid harboring HA-tagged human SGK1 has been 
previously described (Wang et al., 2005). HA-tagged human SGK2 
and SGK3 and FLAG-tagged SGK1 and SGK2 were cloned in 
pcDNA3.1-hygro. FLAG-SGK3 and pEGFP-Rab11 were obtained 
from Addgene (Cambridge, MA). The pLKO.1 plasmid harboring 
sh-PDK1 was purchased from Open Biosystems (Huntsville, AL). 
OKNHE3-S663A has been previously described (Wang et al., 2005). 
SGK3-R90A was generated with the QuickChange II XL Site-
Directed Mutagenesis Kit according to the recommendation by 
the manufacturer (Stratagene, Santa Clara, CA). The presence of 
mutation was confirmed by nucleotide sequencing.
Cell culture and transfection
PS120/NHE3V and PS120 expressing OKNHE3, PS120/OKNHE3, 
have been previously described (Wang et al., 2005; He et al., 2008). 
Caco-2bbe/hNHE3V cells were cultured as previously described (Lin 
et al., 2010). Transfection was performed using the Neon Transfec-
tion System according to the manufacturer’s recommendation (Invit-
rogen, Carlsbad, CA). Stable cell lines expressing SGK plasmids 
were selected with 800 μg/ml of neomycin or 600 μg/ml of hygro-
FIGURE 8: SGK3-mediated activation of NHE3 is dependent on PI3K and PDK1. (A) PS120/NHE3V/HA-SGK3 cells were 
pretreated with 1 μM RU or 20 μM LY prior to treatment with 1 μM Dex or carrier for 15 min. SGK3 protein was purified 
by immunoprecipitation, and the kinase activity was determined by TR-FRET. n = 3. (B) PS120/NHE3V/HA-SGK3 cells 
were stably transfected with sh-PDK1 or pLKO.1, and the expression level of PDK1 was determined by Western blotting 
using an anti-PDK1 antibody. (C) PS120/NHE3V/HA-SGK3 cells transfected with sh-PDK1 or pLKO.1 were treated with 
1 μM Dex or carrier for 15 min. SGK3 protein was purified, and kinase activity was determined. n = 3. (D) NHE3 activities 
were determined in PS120/NHE3V/HA-SGK3 cells pretreated with RU or LY prior to treatment with Dex. (E) NHE3 
activities in PS120/NHE3V/HA-SGK3 cells transfected with sh-PDK1 or pLKO.1 are shown. (A–E) n.s., not significant. 
*, p < 0.01 and **, p < 0.05, compared with respective controls. n = 6. (F) PS120/NHE3V cells expressing HA-SGK3 were 
serum-starved and treated with Dex or carrier for 15 min. Colocalization of SGK3 (green) and phospho-PDK1(p-PDK1, 
red) was determined using anti-HA and anti-p-PDK1 antibodies, respectively. (G) The graph represents Pearson’s 
coefficient of SGK3 and p-PDK1 colocalization from 10 independent fields of cells. *, p < 0.01 compared with the 
control. (H) Colocalization of GFP-Rab11 (green) and p-PDK1 (red) in PS120/NHE3V cells treated with or without Dex for 
15 min is shown. Scale bar: 10 μm. Insets show high magnification of merged signals. (I) Pearson’s coefficient of 
GFP-Rab11 and p-PDK1 colocalization from 10 independent fields of cells. *, p < 0.01 compared with the control.
mycin. Both PS120 fibroblasts and Caco-2bbe epithelial cells were 
cultured in DMEM supplemented with 1 mM sodium pyruvate, 
50 U/ml penicillin, 50 μg/ml streptomycin, and 10% fetal bovine se-
rum in a 5% CO2 humidified incubator at 37°C.
Immunoprecipitation and kinase activity assay
PS120/NHE3V cells overexpressing HA-SGK1, HA-SGK2, HA-SGK3, 
or HA-SGK3-R90A were treated with 1 μM Dex. Cells were then ly-
sed in lysis buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 
5 mM β-glycerophosphate, 2.5 mM sodium pyrophosphate, 1 mM 
Na2EDTA, 1 mM ethylene glycol tetraacetic acid (EGTA), 1 mM 
Na3VO4, 1 mM sodium fluoride, 10 mM 1 μg/ml leupeptin, 1% Tri-
ton X-100, and protease inhibitor cocktail tablets (Roche, Indianapo-
lis, IN). The crude lysate was sonicated twice for 15 s and spun at 
14,000 × g for 15 min. Protein concentration was determined by the 
bicinchoninic acid assay (Sigma). Two milligrams of lysate was incu-
bated overnight with or without anti-HA antibody. The immunocom-
plex was purified by incubation with 80 μl of protein A-Sepharose 
beads for 1 h, which was followed by three washes in lysis buffer and 
two washes in phosphate-buffered saline (PBS). Beads bound with 
SGK1, SGK2, SGK3, or SGK3-R90A were eluted with 50 μg/ml HA 
peptide (Covance) in elution buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 270 mM sucrose, 1 mM Na3VO4, 0.1 mM EGTA, 0.2 mM phe-
nylmethylsulfonyl fluoride, 0.1% β-mercaptoethanol and 10% glyc-
erol). An aliquot of eluted protein was resolved by SDS–PAGE and 
immunoblotted with anti-HA antibody to ensure an identical amount 
of protein was used for kinase assay. In vitro kinase assay was deter-
mined with two approaches using 1) [γ-32P]ATP and 2) a nonradioiso-
tope TR-FRET method. For the former, the kinase assay was per-
formed for 20 min at 30°C in 50 μl of reaction volume containing 
10 μl of immunoprecipitate in reaction buffer (20 mM Tris, 100 μM 
ATP, 10 mM MgCl2, 1 mM dithiothreitol [DTT], 10 μCi [γ-32P]ATP) 
and 0.3 mM Crosstide (GRPRTSSFAEG; Upstate, Lake Placid, NY) as 
a substrate. The reaction was stopped with stop solution (1 mM ATP, 
1% bovine serum albumin, and 0.6% HCl), and the reaction mix was 
applied to 2.1 cm p81 Whatman filter paper. After drying at room 
temperature, the filters were washed four times with 25 mM phos-
phoric acid and once with acetone and were then counted in a 
scintillation counter. For the latter nonradioisotope TR-FRET method, 
the assay was performed as previously reported in 384-well plates 
according to the manufacturer’s recommendation (Zhang et al., 
2006). The same amount of eluted protein was incubated with 
ULight-PLK(Ser137) peptide (PerkinElmer, Waltham, MA) for 60 min 
at room temperature in kinase assay buffer (50 mM HEPES, pH 7.5, 
1 mM EGTA, 10 mM MgCl2, 2 mM DTT, and 0.01% Tween-20). The 
reaction was then stopped by addition of stop solution (detection 
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twice in PBS and incubated for 10 min in borate buffer (154 mM 
NaCl, 7.2 mM KCl, 1.8 mM CaCl2, and 10 mM H3BO3, pH 9.0). Cells 
were then incubated for 40 min with 0.5 mg/ml NHS-SS-biotin 
(Pierce) in borate buffer. Unbound NHS-SS-biotin was quenched with 
Tris buffer (20 mM Tris, 120 mM NaCl, pH 7.4). Cells were then rinsed 
with PBS, scraped, lysed in the lysis buffer described above, and 
sonicated twice for 15 s. The lysate was agitated for 30 min and spun 
at 14,000 × g for 30 min to remove the insoluble cell debris. An ali-
quot was retained as the total fraction representing the total cellular 
NHE3. Protein concentration was determined, and 1 mg of lysate 
was then incubated with streptavidin-agarose beads (Pierce) for 2 h. 
The strepavidin-agarose beads were washed three times in lysis buf-
fer and twice in PBS. All the above procedures were performed at 
buffer containing 40 mM EDTA) for 5 min, which was followed by 
application of detection mix (2 nM Europium-anti-phospho-
PLK(Ser137) [PerkinElmer, Winooski, VT] in detection buffer) and 
incubation for 60 min at room temperature. The signal was de-
termined with BioTek plate reader in a TR-FRET mode (emission at 
665 nm, excitation at 320 nm) and recorded for calibration of en-
zyme activity.
Surface biotinylation
Surface biotinylation of NHE3 was performed as previously described 
(He et al., 2010). Briefly, PS120/NHE3V cells were serum-starved for 
4 h and Caco-2bbe/hNHE3V cells for 24 h prior to treatment with 
1 μM Dex for indicated time periods (Figure 5A). Cells were rinsed 
FIGURE 9: SGK3 mediates an acute activation of NHE3 by Dex in Caco-2bbe cells. (A) Caco-2bbe/hNHE3V/HA-SGK3 
and Caco-2bbe/hNHE3V/pcDNA cells were treated with Dex or carrier for 15 min. NHE3 activities were measured in 
the presence of 50 μM Hoe-694. The rates of pH recovery at pHi 6.7 are shown. n = 6. n.s., not significant. *, p < 0.01 
compared with the untreated control. (B) Cellular localization of SGK3 (green) and NHE3 (red) in Caco-2bbe cells was 
determined by indirect immunofluorescence with anti-HA and anti-VSVG antibodies, respectively. Confocal focal planes 
(top) and cross-sections (bottom) are shown. Scale bar: 10 μm. (C) Caco-2bbe/hNHE3V/HA-SGK3 cells were treated 
with Dex or carrier for 15 min. NHE3 expression (red) at the apical membrane was determined with anti-VSVG antibody. 
WGA (green) staining of glycoprotein at plasma membrane is shown as a marker of apical labeling. Confocal focal (large 
panel) and cross-sectional (small panel) views are shown. Scale bar: 10 μm. (D) The amount of NHE3 protein on the 
plasma membrane was determined by surface biotinylation, as detailed in Materials and Methods. The amount of 
surface (S) NHE3 was normalized to total (T) NHE3, and relative changes (%) are shown below the blotting. n = 3. *, 
p < 0.01 compared with the untreated control.
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inverted microscope and were superfused with NH4+ buffer (40 mM 
NH4Cl, 90 mM NaCl, 20 mM HEPES, 5 mM KCl, 1 mM TMA-PO4, 
2 mM CaCl2, 1 mM MgSO4, and 25 mM glucose) and subsequently 
with TMA+ buffer (130 mM TMA-Cl, 20 mM HEPES, 5 mM KCl, 1 mM 
TMA-PO4, 2 mM CaCl2, 1 mM MgSO4, and 25 mM glucose). Na+ 
buffer supplemented with 50 μM Hoe-694 (NHE1 and NHE2 inhibi-
tor) or 10 μM S-3226 (NHE3 inhibitor) was then reintroduced to drive 
Na+-dependent pH recovery. NHE3 activity in cultured cells was like-
wise determined. PS120 fibroblasts and Caco-2bbe cells seeded on 
coverslips were grown to 80–90% confluence and 5–7 d postconflu-
ence, respectively. PS120 and Caco-2bbe cells were serum-starved 
for 4 h and overnight, respectively, prior to Dex treatment and NHE3 
activity measurement. The rate of Na+-dependent pH recovery was 
calculated by determining slopes along the early stage of pH recov-
ery by linear least-squares analysis over a minimum of 9 s. Calibration 
of the fluorescence signal was performed using the K+/H+ ionophore 
nigericin as previously described (Lamprecht et al., 1998). Compari-
sons of Na+/H+ exchange were made between measurements made 
on the same day. The microfluorometry was performed on a Nikon 
(Melville, NY) TE200 inverted microscope with a Nikon CFI Super 
Fluor 40× objective, coupled to a Lambda 10-2 filter wheel controller 
equipped with a multiwavelength filter set designed for BCECF-AM. 
Photometric data were acquired using MetaFluor software (Molecu-
lar Devices, Sunnyvale, CA).
Confocal immunofluorescence
PS120 cells grown on coverslips and Caco-2bbe cells grown on 
Transwell filters were fixed and permeabilized as described previ-
ously (He et al., 2008). For labeling of glycoprotein as a marker of 
apical membrane, Caco-2bbe cells were subjected to 10-min incu-
bation with Alexa Fluor 647-conjugated WGA (Invitrogen) prior to 
fixation. Cells were then stained with a rabbit monoclonal anti-HA 
antibody, a rabbit or mouse anti-FLAG antibody, a mouse monoclo-
nal anti-VSVG antibody, a rabbit monoclonal anti–p-PDK1 antibody, 
or a mouse monoclonal anti-Rab5 antibody for 1 h at room tem-
perature. Following three washes, 10 min each, with PBS, the cells 
were incubated with Alexa Fluor 488-conjugated goat anti–rabbit 
immunoglobulin G (IgG), Alexa Fluor 546-conjugated goat anti–
rabbit IgG, Alexa Fluor 555-conjugated goat anti–mouse IgG, or 
Alexa Fluor 647–conjugated donkey anti–mouse IgG (Invitrogen) 
for 1 h at room temperature. After three 10-min washes with PBS, 
the specimens were mounted with ProLong Gold Antifade Reagent 
(Invitrogen) and observed under a Zeiss LSM510 laser confocal mi-
croscope (Zeiss Microimaging, Thornwood, NY) coupled to a Zeiss 
Axioplan2e with 60× Plan-Apochromat oil lenses. For quantitative 
evaluation of the colocalization of green (SGK3 or GFP-Rab11) and 
red (p-PDK1) fluorescence signals, 10 random fields of cells were 
selected. Pearson’s correlation coefficient was determined for each 
cell using MetaMorph (Molecular Devices).
Statistical analysis
Results are presented as the mean ± SE. Statistical significance was 
assessed by Student’s t test using the SPSS statistical program (SPSS, 
IBM, New York, NY). p < 0.05 is considered significant.
4°C or on ice. Biotinylated surface proteins were then eluted by boil-
ing the beads at 95°C for 10 min. Dilutions of the total and surface 
NHE3 were resolved by SDS–PAGE and immunoblotted with an anti-
VSVG antibody. Densitometric analysis was performed using Scion 
Image software (www.nist.gov/lispix/imlab/prelim/dnld.html).
Na+-dependent intracellular pH recovery
Mice were injected with Dex (2 mg/kg body weight) intraperito-
neally, and the animals were killed 4 or 24 h later. Isolation of villi 
was performed as previously described (Grahammer et al., 2006). 
In brief, mice were killed and the ileum was flushed with cold 
PBS to remove food particles. A segment of ileum ∼10 cm from 
the cecum was always selected, opened longitudinally, and stabi-
lized on a cooled stage. The villi were then carefully dissected 
under a stereomicroscope using sharpened microdissection scis-
sors. Isolated villi were mounted on coverslips and covered 
with light- and solution-penetrable polycarbonate membrane 
(GE Healthcare, Minnetonka, MN). The intrinsic buffering capac-
ity (IBC) of isolated villi was calibrated as previously described 
(Grahammer et al., 2006) to confirm the IBC is similar between 
Sgk1flox/flox and Sgk1flox/flox;Villin-Cre villi.
The Na+-dependent changes in intracellular pH (pHi) of isolated 
villi were determined with the use of the ratio-fluorometric (excita-
tion: 495 and 440 nm, emission: 530 nm), pH-sensitive dye 2′,7′-bis-(2-
carboxyethyl)-5-carboxyfluorescein acetoxymethyl ester (BCECF-
AM; Sigma; Lamprecht et al., 1998; He et al., 2008). Briefly, villi were 
washed in Na+ buffer (130 mM NaCl, 20 mM HEPES, 5 mM KCl, 1 
mM tetramethylammonium-PO4 [TMA-PO4], 2 mM CaCl2, 1 mM 
MgSO4, and 25 mM glucose) and then were dye-loaded by incubat-
ing with 6.5 μM BCECF-AM in the same solution for 10 min. The 
coverslips were mounted on a perfusion chamber mounted on an 
FIGURE 10: A schematic model of GC-mediated acute activation of 
NHE3 via SGK3. Previous studies showed that GCs bind to GR, and 
activated GR interacts with the p85 regulatory subunit of PI3K and 
recruits the p110 catalytic subunit in the cytoplasm (Hafezi-
Moghadam et al., 2002; Limbourg et al., 2002; Hu et al., 2009). PI3K 
activates PDK1 by phosphorylating PDK1, which acutely mobilizes to 
recycling endosomes (RE), where SGK3 and NHE3 are expressed. 
PDK1 then activates SGK3, which in turn phosphorylates NHE3 and 
induces exocytotic insertion of NHE3 into the plasma membrane 
(PM). This cascade occurs as part of the acute NHE3 activation by Dex 
involving SGK3. In the absence of SGK3, the activated PDK1 diffuses 
through cytoplasmic matrix and activates SGK1 or SGK2. Activated 
SGK1 and SGK2 then phosphorylate NHE3 at endosomes and 
potentiate trafficking of NHE3 to PM, a later pathway of NHE3 
regulation.
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